PATENT CLAIM ANALYSIS

Application Number: 15915278
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "252140"]

Abstract:
Provided herein are methods of treating a cognitive deficit, including cognitive deficits associated with a Fmr1 genetic defect. More particularly, provided herein are methods in which an effective amount of a MDM2-p53 pathway inhibitor is administered to a subject afflicted with at least one cognitive deficit, whereby administration of the inhibitor improves, enhances, or rescues at least one cognitive deficit in the subject.

Claim (Index 6):
The method of  claim 5 , wherein the Fmr1 genetic defect comprises a pre-mutation FXS allele.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.59091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15274983', '14128154', '14994705', '14917169', '15818850']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7175285805059446
- 35 USC 102 Novelty (BERT): 0.670170889675701
- Combined Prediction Score: 0.7127928114229203
- Mean Citation Score: 331.6576740000001
- Max Citation Score: 665.2191
- Similarity Product: 620.4034098455785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test